Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma, Radiotherapy, Sorafenib Intervention: Radiation: concurrent sorafenib and IMRT, followed sorafenib maintenance Sponsor: Chinese Academy of Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Intensity-Modulated Radiation Therapy | Liver Cancer | Study